Global Intravenous Immunoglobulin (IVIg) Supply, Demand and Key Producers, 2026-2032
The global Intravenous Immunoglobulin (IVIg) market size is expected to reach $ 33576 million by 2032, rising at a market growth of 7.4% CAGR during the forecast period (2026-2032).
Intravenous Immunoglobulin (IVIg) is a highly purified immunoglobulin preparation derived from pooled human plasma, produced through cold ethanol fractionation, chromatographic purification, and validated viral inactivation processes. The primary component is polyclonal IgG antibodies. IVIg exerts therapeutic effects by supplementing humoral immunity and modulating immune responses. It is widely used in primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and inflammatory diseases. Its mechanisms include pathogen neutralization, Fc receptor modulation, suppression of autoantibodies, and cytokine regulation. As a premium blood-derived product, IVIg plays an indispensable role in critical care and long-term management of immune-related disorders.In 2025, global Intravenous Immunoglobulin production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
Rising diagnosis rates of primary immunodeficiency diseases and increasing prevalence of autoimmune disorders provide long-term demand growth for IVIg. Expansion into neurological indications and rare disease therapies continues to broaden clinical applications. Aging populations and the growing burden of chronic diseases further strengthen demand for immunomodulatory treatments. Expanded reimbursement coverage and regulatory standardization in the blood products sector support steady market expansion. Technological advancements that enhance purification efficiency and product safety also reinforce industry growth momentum.
IVIg production heavily depends on human plasma resources, which are inherently constrained by donation systems, regulatory policies, and ethical considerations. The manufacturing process is complex, requiring stringent quality control and viral safety measures, leading to high operational costs. In some regions, pricing regulations or centralized procurement mechanisms may limit profit margins. Rapid development of novel biologics and targeted immune therapies could create substitution pressure in certain indications. In addition, fluctuations in global plasma supply chains may impact market stability.
Downstream demand is concentrated in tertiary hospitals, neurology specialty centers, immunology clinics, and rare disease treatment institutions. Clinical use is expanding from acute rescue therapy to long-term maintenance regimens. High-concentration formulations and subcutaneous alternatives are gradually penetrating the market, although IVIg remains dominant in acute and severe cases. Precision stratification and multidisciplinary treatment models are improving therapeutic value per patient. International markets increasingly prioritize products with high safety standards and superior purity profiles.
The core raw material for IVIg is plasma collected from healthy donors, with quality directly influencing product safety and efficacy. Plasma collection relies on established donation networks, strict screening systems, and compliant regulatory environments. Production requires separation reagents, chromatography resins, viral inactivation solvents, and single-use bioprocess consumables. As global competition for plasma resources intensifies, upstream supply assurance has become a critical competitive barrier. Cold chain logistics and batch release systems are also essential to ensuring stable and continuous product supply.
This report studies the global Intravenous Immunoglobulin (IVIg) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin (IVIg) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin (IVIg) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Immunoglobulin (IVIg) total production and demand, 2021-2032, (K Bottle)
Global Intravenous Immunoglobulin (IVIg) total production value, 2021-2032, (USD Million)
Global Intravenous Immunoglobulin (IVIg) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle), (based on production site)
Global Intravenous Immunoglobulin (IVIg) consumption by region & country, CAGR, 2021-2032 & (K Bottle)
U.S. VS China: Intravenous Immunoglobulin (IVIg) domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin (IVIg) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Bottle)
Global Intravenous Immunoglobulin (IVIg) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle)
Global Intravenous Immunoglobulin (IVIg) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle)
This report profiles key players in the global Intravenous Immunoglobulin (IVIg) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin (IVIg) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Bottle) and average price (USD/Bottle) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Intravenous Immunoglobulin (IVIg) Market, By Region:
1. How big is the global Intravenous Immunoglobulin (IVIg) market?
2. What is the demand of the global Intravenous Immunoglobulin (IVIg) market?
3. What is the year over year growth of the global Intravenous Immunoglobulin (IVIg) market?
4. What is the production and production value of the global Intravenous Immunoglobulin (IVIg) market?
5. Who are the key producers in the global Intravenous Immunoglobulin (IVIg) market?
6. What are the growth factors driving the market demand?
Intravenous Immunoglobulin (IVIg) is a highly purified immunoglobulin preparation derived from pooled human plasma, produced through cold ethanol fractionation, chromatographic purification, and validated viral inactivation processes. The primary component is polyclonal IgG antibodies. IVIg exerts therapeutic effects by supplementing humoral immunity and modulating immune responses. It is widely used in primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and inflammatory diseases. Its mechanisms include pathogen neutralization, Fc receptor modulation, suppression of autoantibodies, and cytokine regulation. As a premium blood-derived product, IVIg plays an indispensable role in critical care and long-term management of immune-related disorders.In 2025, global Intravenous Immunoglobulin production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
Rising diagnosis rates of primary immunodeficiency diseases and increasing prevalence of autoimmune disorders provide long-term demand growth for IVIg. Expansion into neurological indications and rare disease therapies continues to broaden clinical applications. Aging populations and the growing burden of chronic diseases further strengthen demand for immunomodulatory treatments. Expanded reimbursement coverage and regulatory standardization in the blood products sector support steady market expansion. Technological advancements that enhance purification efficiency and product safety also reinforce industry growth momentum.
IVIg production heavily depends on human plasma resources, which are inherently constrained by donation systems, regulatory policies, and ethical considerations. The manufacturing process is complex, requiring stringent quality control and viral safety measures, leading to high operational costs. In some regions, pricing regulations or centralized procurement mechanisms may limit profit margins. Rapid development of novel biologics and targeted immune therapies could create substitution pressure in certain indications. In addition, fluctuations in global plasma supply chains may impact market stability.
Downstream demand is concentrated in tertiary hospitals, neurology specialty centers, immunology clinics, and rare disease treatment institutions. Clinical use is expanding from acute rescue therapy to long-term maintenance regimens. High-concentration formulations and subcutaneous alternatives are gradually penetrating the market, although IVIg remains dominant in acute and severe cases. Precision stratification and multidisciplinary treatment models are improving therapeutic value per patient. International markets increasingly prioritize products with high safety standards and superior purity profiles.
The core raw material for IVIg is plasma collected from healthy donors, with quality directly influencing product safety and efficacy. Plasma collection relies on established donation networks, strict screening systems, and compliant regulatory environments. Production requires separation reagents, chromatography resins, viral inactivation solvents, and single-use bioprocess consumables. As global competition for plasma resources intensifies, upstream supply assurance has become a critical competitive barrier. Cold chain logistics and batch release systems are also essential to ensuring stable and continuous product supply.
This report studies the global Intravenous Immunoglobulin (IVIg) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin (IVIg) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin (IVIg) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Immunoglobulin (IVIg) total production and demand, 2021-2032, (K Bottle)
Global Intravenous Immunoglobulin (IVIg) total production value, 2021-2032, (USD Million)
Global Intravenous Immunoglobulin (IVIg) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle), (based on production site)
Global Intravenous Immunoglobulin (IVIg) consumption by region & country, CAGR, 2021-2032 & (K Bottle)
U.S. VS China: Intravenous Immunoglobulin (IVIg) domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin (IVIg) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Bottle)
Global Intravenous Immunoglobulin (IVIg) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle)
Global Intravenous Immunoglobulin (IVIg) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Bottle)
This report profiles key players in the global Intravenous Immunoglobulin (IVIg) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin (IVIg) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Bottle) and average price (USD/Bottle) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Intravenous Immunoglobulin (IVIg) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- IVIg Liquid
- IVIg Powder
- Low Concentration
- Medium Concentration
- High Concentration
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
1. How big is the global Intravenous Immunoglobulin (IVIg) market?
2. What is the demand of the global Intravenous Immunoglobulin (IVIg) market?
3. What is the year over year growth of the global Intravenous Immunoglobulin (IVIg) market?
4. What is the production and production value of the global Intravenous Immunoglobulin (IVIg) market?
5. Who are the key producers in the global Intravenous Immunoglobulin (IVIg) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 World Intravenous Immunoglobulin (IVIg) Supply & Forecast
1.2.1 World Intravenous Immunoglobulin (IVIg) Production Value (2021 & 2025 & 2032)
1.2.2 World Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.2.3 World Intravenous Immunoglobulin (IVIg) Pricing Trends (2021-2032)
1.3 World Intravenous Immunoglobulin (IVIg) Production by Region (Based on Production Site)
1.3.1 World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021-2032)
1.3.2 World Intravenous Immunoglobulin (IVIg) Production by Region (2021-2032)
1.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Region (2021-2032)
1.3.4 North America Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.3.5 Europe Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.3.6 China Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin (IVIg) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin (IVIg) Major Market Trends
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin (IVIg) Demand (2021-2032)
2.2 World Intravenous Immunoglobulin (IVIg) Consumption by Region
2.2.1 World Intravenous Immunoglobulin (IVIg) Consumption by Region (2021-2026)
2.2.2 World Intravenous Immunoglobulin (IVIg) Consumption Forecast by Region (2027-2032)
2.3 United States Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.4 China Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.5 Europe Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.6 Japan Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.7 South Korea Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.8 ASEAN Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.9 India Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin (IVIg) Production Value by Manufacturer (2021-2026)
3.2 World Intravenous Immunoglobulin (IVIg) Production by Manufacturer (2021-2026)
3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2021-2026)
3.4 Intravenous Immunoglobulin (IVIg) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin (IVIg) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin (IVIg) in 2025
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin (IVIg) in 2025
3.6 Intravenous Immunoglobulin (IVIg) Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin (IVIg) Market: Region Footprint
3.6.2 Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
4.5 China Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share
4.5.1 China Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.5.3 China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
4.6 Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 IVIg Liquid
5.2.2 IVIg Powder
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin (IVIg) Production by Type (2021-2032)
5.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Type (2021-2032)
5.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TREATMENT SETTING
6.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Treatment Setting: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Treatment Setting
6.2.1 Low Concentration
6.2.2 Medium Concentration
6.2.3 High Concentration
6.3 Market Segment by Treatment Setting
6.3.1 World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2021-2032)
6.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2021-2032)
6.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Immunodeficiency
7.2.2 Autoimmune Disease
7.2.3 Acute Infection
7.3 Market Segment by Application
7.3.1 World Intravenous Immunoglobulin (IVIg) Production by Application (2021-2032)
7.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Application (2021-2032)
7.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Takeda
8.1.1 Takeda Details
8.1.2 Takeda Major Business
8.1.3 Takeda Intravenous Immunoglobulin (IVIg) Product and Services
8.1.4 Takeda Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Takeda Recent Developments/Updates
8.1.6 Takeda Competitive Strengths & Weaknesses
8.2 CSL
8.2.1 CSL Details
8.2.2 CSL Major Business
8.2.3 CSL Intravenous Immunoglobulin (IVIg) Product and Services
8.2.4 CSL Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 CSL Recent Developments/Updates
8.2.6 CSL Competitive Strengths & Weaknesses
8.3 Grifols
8.3.1 Grifols Details
8.3.2 Grifols Major Business
8.3.3 Grifols Intravenous Immunoglobulin (IVIg) Product and Services
8.3.4 Grifols Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Grifols Recent Developments/Updates
8.3.6 Grifols Competitive Strengths & Weaknesses
8.4 Octapharma
8.4.1 Octapharma Details
8.4.2 Octapharma Major Business
8.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
8.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Octapharma Recent Developments/Updates
8.4.6 Octapharma Competitive Strengths & Weaknesses
8.5 Kedrion
8.5.1 Kedrion Details
8.5.2 Kedrion Major Business
8.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
8.5.4 Kedrion Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Kedrion Recent Developments/Updates
8.5.6 Kedrion Competitive Strengths & Weaknesses
8.6 LFB Group
8.6.1 LFB Group Details
8.6.2 LFB Group Major Business
8.6.3 LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
8.6.4 LFB Group Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 LFB Group Recent Developments/Updates
8.6.6 LFB Group Competitive Strengths & Weaknesses
8.7 Biotest
8.7.1 Biotest Details
8.7.2 Biotest Major Business
8.7.3 Biotest Intravenous Immunoglobulin (IVIg) Product and Services
8.7.4 Biotest Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Biotest Recent Developments/Updates
8.7.6 Biotest Competitive Strengths & Weaknesses
8.8 BPL
8.8.1 BPL Details
8.8.2 BPL Major Business
8.8.3 BPL Intravenous Immunoglobulin (IVIg) Product and Services
8.8.4 BPL Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 BPL Recent Developments/Updates
8.8.6 BPL Competitive Strengths & Weaknesses
8.9 RAAS
8.9.1 RAAS Details
8.9.2 RAAS Major Business
8.9.3 RAAS Intravenous Immunoglobulin (IVIg) Product and Services
8.9.4 RAAS Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 RAAS Recent Developments/Updates
8.9.6 RAAS Competitive Strengths & Weaknesses
8.10 CBPO
8.10.1 CBPO Details
8.10.2 CBPO Major Business
8.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product and Services
8.10.4 CBPO Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 CBPO Recent Developments/Updates
8.10.6 CBPO Competitive Strengths & Weaknesses
8.11 Hualan Bio
8.11.1 Hualan Bio Details
8.11.2 Hualan Bio Major Business
8.11.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.11.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Hualan Bio Recent Developments/Updates
8.11.6 Hualan Bio Competitive Strengths & Weaknesses
8.12 Tiantan Bio
8.12.1 Tiantan Bio Details
8.12.2 Tiantan Bio Major Business
8.12.3 Tiantan Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.12.4 Tiantan Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Tiantan Bio Recent Developments/Updates
8.12.6 Tiantan Bio Competitive Strengths & Weaknesses
8.13 Shuanglin Bio
8.13.1 Shuanglin Bio Details
8.13.2 Shuanglin Bio Major Business
8.13.3 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.13.4 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Shuanglin Bio Recent Developments/Updates
8.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
8.14 Boya Bio
8.14.1 Boya Bio Details
8.14.2 Boya Bio Major Business
8.14.3 Boya Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.14.4 Boya Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Boya Bio Recent Developments/Updates
8.14.6 Boya Bio Competitive Strengths & Weaknesses
8.15 Yuanda Shuyang
8.15.1 Yuanda Shuyang Details
8.15.2 Yuanda Shuyang Major Business
8.15.3 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
8.15.4 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Yuanda Shuyang Recent Developments/Updates
8.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
8.16 Weiguang Bio
8.16.1 Weiguang Bio Details
8.16.2 Weiguang Bio Major Business
8.16.3 Weiguang Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.16.4 Weiguang Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Weiguang Bio Recent Developments/Updates
8.16.6 Weiguang Bio Competitive Strengths & Weaknesses
8.17 Nanyue Bio
8.17.1 Nanyue Bio Details
8.17.2 Nanyue Bio Major Business
8.17.3 Nanyue Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.17.4 Nanyue Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Nanyue Bio Recent Developments/Updates
8.17.6 Nanyue Bio Competitive Strengths & Weaknesses
8.18 KM Biologics
8.18.1 KM Biologics Details
8.18.2 KM Biologics Major Business
8.18.3 KM Biologics Intravenous Immunoglobulin (IVIg) Product and Services
8.18.4 KM Biologics Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 KM Biologics Recent Developments/Updates
8.18.6 KM Biologics Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Intravenous Immunoglobulin (IVIg) Industry Chain
9.2 Intravenous Immunoglobulin (IVIg) Upstream Analysis
9.2.1 Intravenous Immunoglobulin (IVIg) Core Raw Materials
9.2.2 Main Manufacturers of Intravenous Immunoglobulin (IVIg) Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Intravenous Immunoglobulin (IVIg) Production Mode
9.6 Intravenous Immunoglobulin (IVIg) Procurement Model
9.7 Intravenous Immunoglobulin (IVIg) Industry Sales Model and Sales Channels
9.7.1 Intravenous Immunoglobulin (IVIg) Sales Model
9.7.2 Intravenous Immunoglobulin (IVIg) Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 World Intravenous Immunoglobulin (IVIg) Supply & Forecast
1.2.1 World Intravenous Immunoglobulin (IVIg) Production Value (2021 & 2025 & 2032)
1.2.2 World Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.2.3 World Intravenous Immunoglobulin (IVIg) Pricing Trends (2021-2032)
1.3 World Intravenous Immunoglobulin (IVIg) Production by Region (Based on Production Site)
1.3.1 World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021-2032)
1.3.2 World Intravenous Immunoglobulin (IVIg) Production by Region (2021-2032)
1.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Region (2021-2032)
1.3.4 North America Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.3.5 Europe Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.3.6 China Intravenous Immunoglobulin (IVIg) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin (IVIg) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin (IVIg) Major Market Trends
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin (IVIg) Demand (2021-2032)
2.2 World Intravenous Immunoglobulin (IVIg) Consumption by Region
2.2.1 World Intravenous Immunoglobulin (IVIg) Consumption by Region (2021-2026)
2.2.2 World Intravenous Immunoglobulin (IVIg) Consumption Forecast by Region (2027-2032)
2.3 United States Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.4 China Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.5 Europe Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.6 Japan Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.7 South Korea Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.8 ASEAN Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
2.9 India Intravenous Immunoglobulin (IVIg) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin (IVIg) Production Value by Manufacturer (2021-2026)
3.2 World Intravenous Immunoglobulin (IVIg) Production by Manufacturer (2021-2026)
3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2021-2026)
3.4 Intravenous Immunoglobulin (IVIg) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin (IVIg) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin (IVIg) in 2025
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin (IVIg) in 2025
3.6 Intravenous Immunoglobulin (IVIg) Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin (IVIg) Market: Region Footprint
3.6.2 Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin (IVIg) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Intravenous Immunoglobulin (IVIg) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
4.5 China Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share
4.5.1 China Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.5.3 China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
4.6 Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 IVIg Liquid
5.2.2 IVIg Powder
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin (IVIg) Production by Type (2021-2032)
5.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Type (2021-2032)
5.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TREATMENT SETTING
6.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Treatment Setting: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Treatment Setting
6.2.1 Low Concentration
6.2.2 Medium Concentration
6.2.3 High Concentration
6.3 Market Segment by Treatment Setting
6.3.1 World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2021-2032)
6.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2021-2032)
6.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Intravenous Immunoglobulin (IVIg) Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Immunodeficiency
7.2.2 Autoimmune Disease
7.2.3 Acute Infection
7.3 Market Segment by Application
7.3.1 World Intravenous Immunoglobulin (IVIg) Production by Application (2021-2032)
7.3.2 World Intravenous Immunoglobulin (IVIg) Production Value by Application (2021-2032)
7.3.3 World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Takeda
8.1.1 Takeda Details
8.1.2 Takeda Major Business
8.1.3 Takeda Intravenous Immunoglobulin (IVIg) Product and Services
8.1.4 Takeda Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Takeda Recent Developments/Updates
8.1.6 Takeda Competitive Strengths & Weaknesses
8.2 CSL
8.2.1 CSL Details
8.2.2 CSL Major Business
8.2.3 CSL Intravenous Immunoglobulin (IVIg) Product and Services
8.2.4 CSL Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 CSL Recent Developments/Updates
8.2.6 CSL Competitive Strengths & Weaknesses
8.3 Grifols
8.3.1 Grifols Details
8.3.2 Grifols Major Business
8.3.3 Grifols Intravenous Immunoglobulin (IVIg) Product and Services
8.3.4 Grifols Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Grifols Recent Developments/Updates
8.3.6 Grifols Competitive Strengths & Weaknesses
8.4 Octapharma
8.4.1 Octapharma Details
8.4.2 Octapharma Major Business
8.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
8.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Octapharma Recent Developments/Updates
8.4.6 Octapharma Competitive Strengths & Weaknesses
8.5 Kedrion
8.5.1 Kedrion Details
8.5.2 Kedrion Major Business
8.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
8.5.4 Kedrion Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Kedrion Recent Developments/Updates
8.5.6 Kedrion Competitive Strengths & Weaknesses
8.6 LFB Group
8.6.1 LFB Group Details
8.6.2 LFB Group Major Business
8.6.3 LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
8.6.4 LFB Group Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 LFB Group Recent Developments/Updates
8.6.6 LFB Group Competitive Strengths & Weaknesses
8.7 Biotest
8.7.1 Biotest Details
8.7.2 Biotest Major Business
8.7.3 Biotest Intravenous Immunoglobulin (IVIg) Product and Services
8.7.4 Biotest Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Biotest Recent Developments/Updates
8.7.6 Biotest Competitive Strengths & Weaknesses
8.8 BPL
8.8.1 BPL Details
8.8.2 BPL Major Business
8.8.3 BPL Intravenous Immunoglobulin (IVIg) Product and Services
8.8.4 BPL Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 BPL Recent Developments/Updates
8.8.6 BPL Competitive Strengths & Weaknesses
8.9 RAAS
8.9.1 RAAS Details
8.9.2 RAAS Major Business
8.9.3 RAAS Intravenous Immunoglobulin (IVIg) Product and Services
8.9.4 RAAS Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 RAAS Recent Developments/Updates
8.9.6 RAAS Competitive Strengths & Weaknesses
8.10 CBPO
8.10.1 CBPO Details
8.10.2 CBPO Major Business
8.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product and Services
8.10.4 CBPO Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 CBPO Recent Developments/Updates
8.10.6 CBPO Competitive Strengths & Weaknesses
8.11 Hualan Bio
8.11.1 Hualan Bio Details
8.11.2 Hualan Bio Major Business
8.11.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.11.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Hualan Bio Recent Developments/Updates
8.11.6 Hualan Bio Competitive Strengths & Weaknesses
8.12 Tiantan Bio
8.12.1 Tiantan Bio Details
8.12.2 Tiantan Bio Major Business
8.12.3 Tiantan Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.12.4 Tiantan Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Tiantan Bio Recent Developments/Updates
8.12.6 Tiantan Bio Competitive Strengths & Weaknesses
8.13 Shuanglin Bio
8.13.1 Shuanglin Bio Details
8.13.2 Shuanglin Bio Major Business
8.13.3 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.13.4 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Shuanglin Bio Recent Developments/Updates
8.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
8.14 Boya Bio
8.14.1 Boya Bio Details
8.14.2 Boya Bio Major Business
8.14.3 Boya Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.14.4 Boya Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Boya Bio Recent Developments/Updates
8.14.6 Boya Bio Competitive Strengths & Weaknesses
8.15 Yuanda Shuyang
8.15.1 Yuanda Shuyang Details
8.15.2 Yuanda Shuyang Major Business
8.15.3 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
8.15.4 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Yuanda Shuyang Recent Developments/Updates
8.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
8.16 Weiguang Bio
8.16.1 Weiguang Bio Details
8.16.2 Weiguang Bio Major Business
8.16.3 Weiguang Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.16.4 Weiguang Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Weiguang Bio Recent Developments/Updates
8.16.6 Weiguang Bio Competitive Strengths & Weaknesses
8.17 Nanyue Bio
8.17.1 Nanyue Bio Details
8.17.2 Nanyue Bio Major Business
8.17.3 Nanyue Bio Intravenous Immunoglobulin (IVIg) Product and Services
8.17.4 Nanyue Bio Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Nanyue Bio Recent Developments/Updates
8.17.6 Nanyue Bio Competitive Strengths & Weaknesses
8.18 KM Biologics
8.18.1 KM Biologics Details
8.18.2 KM Biologics Major Business
8.18.3 KM Biologics Intravenous Immunoglobulin (IVIg) Product and Services
8.18.4 KM Biologics Intravenous Immunoglobulin (IVIg) Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 KM Biologics Recent Developments/Updates
8.18.6 KM Biologics Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Intravenous Immunoglobulin (IVIg) Industry Chain
9.2 Intravenous Immunoglobulin (IVIg) Upstream Analysis
9.2.1 Intravenous Immunoglobulin (IVIg) Core Raw Materials
9.2.2 Main Manufacturers of Intravenous Immunoglobulin (IVIg) Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Intravenous Immunoglobulin (IVIg) Production Mode
9.6 Intravenous Immunoglobulin (IVIg) Procurement Model
9.7 Intravenous Immunoglobulin (IVIg) Industry Sales Model and Sales Channels
9.7.1 Intravenous Immunoglobulin (IVIg) Sales Model
9.7.2 Intravenous Immunoglobulin (IVIg) Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2021-2026)
Table 5. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2027-2032)
Table 6. World Intravenous Immunoglobulin (IVIg) Production by Region (2021-2026) & (K Bottle)
Table 7. World Intravenous Immunoglobulin (IVIg) Production by Region (2027-2032) & (K Bottle)
Table 8. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2021-2026)
Table 9. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2027-2032)
Table 10. World Intravenous Immunoglobulin (IVIg) Average Price by Region (2021-2026) & (USD/Bottle)
Table 11. World Intravenous Immunoglobulin (IVIg) Average Price by Region (2027-2032) & (USD/Bottle)
Table 12. Intravenous Immunoglobulin (IVIg) Major Market Trends
Table 13. World Intravenous Immunoglobulin (IVIg) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Bottle)
Table 14. World Intravenous Immunoglobulin (IVIg) Consumption by Region (2021-2026) & (K Bottle)
Table 15. World Intravenous Immunoglobulin (IVIg) Consumption Forecast by Region (2027-2032) & (K Bottle)
Table 16. World Intravenous Immunoglobulin (IVIg) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin (IVIg) Producers in 2025
Table 18. World Intravenous Immunoglobulin (IVIg) Production by Manufacturer (2021-2026) & (K Bottle)
Table 19. Production Market Share of Key Intravenous Immunoglobulin (IVIg) Producers in 2025
Table 20. World Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2021-2026) & (USD/Bottle)
Table 21. Global Intravenous Immunoglobulin (IVIg) Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin (IVIg) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Intravenous Immunoglobulin (IVIg) Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin (IVIg) Competitive Factors
Table 27. Intravenous Immunoglobulin (IVIg) New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin (IVIg) Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin (IVIg) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin (IVIg) Production Comparison, (2021 & 2025 & 2032) & (K Bottle)
Table 31. United States VS China Intravenous Immunoglobulin (IVIg) Consumption Comparison, (2021 & 2025 & 2032) & (K Bottle)
Table 32. United States Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026) & (K Bottle)
Table 36. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 37. China Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production, (2021-2026) & (K Bottle)
Table 41. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 42. Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production, (2021-2026) & (K Bottle)
Table 46. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 47. World Intravenous Immunoglobulin (IVIg) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Intravenous Immunoglobulin (IVIg) Production by Type (2021-2026) & (K Bottle)
Table 49. World Intravenous Immunoglobulin (IVIg) Production by Type (2027-2032) & (K Bottle)
Table 50. World Intravenous Immunoglobulin (IVIg) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Intravenous Immunoglobulin (IVIg) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2026) & (USD/Bottle)
Table 53. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2027-2032) & (USD/Bottle)
Table 54. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Table 55. World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2021-2026) & (K Bottle)
Table 56. World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2027-2032) & (K Bottle)
Table 57. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2021-2026) & (USD Million)
Table 58. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2027-2032) & (USD Million)
Table 59. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2026) & (USD/Bottle)
Table 60. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2027-2032) & (USD/Bottle)
Table 61. World Intravenous Immunoglobulin (IVIg) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Intravenous Immunoglobulin (IVIg) Production by Application (2021-2026) & (K Bottle)
Table 63. World Intravenous Immunoglobulin (IVIg) Production by Application (2027-2032) & (K Bottle)
Table 64. World Intravenous Immunoglobulin (IVIg) Production Value by Application (2021-2026) & (USD Million)
Table 65. World Intravenous Immunoglobulin (IVIg) Production Value by Application (2027-2032) & (USD Million)
Table 66. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2026) & (USD/Bottle)
Table 67. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2027-2032) & (USD/Bottle)
Table 68. Takeda Basic Information, Manufacturing Base and Competitors
Table 69. Takeda Major Business
Table 70. Takeda Intravenous Immunoglobulin (IVIg) Product and Services
Table 71. Takeda Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Takeda Recent Developments/Updates
Table 73. Takeda Competitive Strengths & Weaknesses
Table 74. CSL Basic Information, Manufacturing Base and Competitors
Table 75. CSL Major Business
Table 76. CSL Intravenous Immunoglobulin (IVIg) Product and Services
Table 77. CSL Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. CSL Recent Developments/Updates
Table 79. CSL Competitive Strengths & Weaknesses
Table 80. Grifols Basic Information, Manufacturing Base and Competitors
Table 81. Grifols Major Business
Table 82. Grifols Intravenous Immunoglobulin (IVIg) Product and Services
Table 83. Grifols Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Grifols Recent Developments/Updates
Table 85. Grifols Competitive Strengths & Weaknesses
Table 86. Octapharma Basic Information, Manufacturing Base and Competitors
Table 87. Octapharma Major Business
Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
Table 89. Octapharma Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Octapharma Recent Developments/Updates
Table 91. Octapharma Competitive Strengths & Weaknesses
Table 92. Kedrion Basic Information, Manufacturing Base and Competitors
Table 93. Kedrion Major Business
Table 94. Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
Table 95. Kedrion Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Kedrion Recent Developments/Updates
Table 97. Kedrion Competitive Strengths & Weaknesses
Table 98. LFB Group Basic Information, Manufacturing Base and Competitors
Table 99. LFB Group Major Business
Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
Table 101. LFB Group Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. LFB Group Recent Developments/Updates
Table 103. LFB Group Competitive Strengths & Weaknesses
Table 104. Biotest Basic Information, Manufacturing Base and Competitors
Table 105. Biotest Major Business
Table 106. Biotest Intravenous Immunoglobulin (IVIg) Product and Services
Table 107. Biotest Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Biotest Recent Developments/Updates
Table 109. Biotest Competitive Strengths & Weaknesses
Table 110. BPL Basic Information, Manufacturing Base and Competitors
Table 111. BPL Major Business
Table 112. BPL Intravenous Immunoglobulin (IVIg) Product and Services
Table 113. BPL Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. BPL Recent Developments/Updates
Table 115. BPL Competitive Strengths & Weaknesses
Table 116. RAAS Basic Information, Manufacturing Base and Competitors
Table 117. RAAS Major Business
Table 118. RAAS Intravenous Immunoglobulin (IVIg) Product and Services
Table 119. RAAS Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. RAAS Recent Developments/Updates
Table 121. RAAS Competitive Strengths & Weaknesses
Table 122. CBPO Basic Information, Manufacturing Base and Competitors
Table 123. CBPO Major Business
Table 124. CBPO Intravenous Immunoglobulin (IVIg) Product and Services
Table 125. CBPO Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. CBPO Recent Developments/Updates
Table 127. CBPO Competitive Strengths & Weaknesses
Table 128. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 129. Hualan Bio Major Business
Table 130. Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 131. Hualan Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Hualan Bio Recent Developments/Updates
Table 133. Hualan Bio Competitive Strengths & Weaknesses
Table 134. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 135. Tiantan Bio Major Business
Table 136. Tiantan Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 137. Tiantan Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Tiantan Bio Recent Developments/Updates
Table 139. Tiantan Bio Competitive Strengths & Weaknesses
Table 140. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 141. Shuanglin Bio Major Business
Table 142. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 143. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Shuanglin Bio Recent Developments/Updates
Table 145. Shuanglin Bio Competitive Strengths & Weaknesses
Table 146. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 147. Boya Bio Major Business
Table 148. Boya Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 149. Boya Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Boya Bio Recent Developments/Updates
Table 151. Boya Bio Competitive Strengths & Weaknesses
Table 152. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 153. Yuanda Shuyang Major Business
Table 154. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
Table 155. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Yuanda Shuyang Recent Developments/Updates
Table 157. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 158. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 159. Weiguang Bio Major Business
Table 160. Weiguang Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 161. Weiguang Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Weiguang Bio Recent Developments/Updates
Table 163. Weiguang Bio Competitive Strengths & Weaknesses
Table 164. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 165. Nanyue Bio Major Business
Table 166. Nanyue Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 167. Nanyue Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Nanyue Bio Recent Developments/Updates
Table 169. Nanyue Bio Competitive Strengths & Weaknesses
Table 170. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 171. KM Biologics Major Business
Table 172. KM Biologics Intravenous Immunoglobulin (IVIg) Product and Services
Table 173. KM Biologics Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. KM Biologics Recent Developments/Updates
Table 175. KM Biologics Competitive Strengths & Weaknesses
Table 176. Global Key Players of Intravenous Immunoglobulin (IVIg) Upstream (Raw Materials)
Table 177. Global Intravenous Immunoglobulin (IVIg) Typical Customers
Table 178. Intravenous Immunoglobulin (IVIg) Typical Distributors
Table 1. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Intravenous Immunoglobulin (IVIg) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2021-2026)
Table 5. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2027-2032)
Table 6. World Intravenous Immunoglobulin (IVIg) Production by Region (2021-2026) & (K Bottle)
Table 7. World Intravenous Immunoglobulin (IVIg) Production by Region (2027-2032) & (K Bottle)
Table 8. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2021-2026)
Table 9. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2027-2032)
Table 10. World Intravenous Immunoglobulin (IVIg) Average Price by Region (2021-2026) & (USD/Bottle)
Table 11. World Intravenous Immunoglobulin (IVIg) Average Price by Region (2027-2032) & (USD/Bottle)
Table 12. Intravenous Immunoglobulin (IVIg) Major Market Trends
Table 13. World Intravenous Immunoglobulin (IVIg) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Bottle)
Table 14. World Intravenous Immunoglobulin (IVIg) Consumption by Region (2021-2026) & (K Bottle)
Table 15. World Intravenous Immunoglobulin (IVIg) Consumption Forecast by Region (2027-2032) & (K Bottle)
Table 16. World Intravenous Immunoglobulin (IVIg) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin (IVIg) Producers in 2025
Table 18. World Intravenous Immunoglobulin (IVIg) Production by Manufacturer (2021-2026) & (K Bottle)
Table 19. Production Market Share of Key Intravenous Immunoglobulin (IVIg) Producers in 2025
Table 20. World Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2021-2026) & (USD/Bottle)
Table 21. Global Intravenous Immunoglobulin (IVIg) Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin (IVIg) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Intravenous Immunoglobulin (IVIg) Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin (IVIg) Competitive Factors
Table 27. Intravenous Immunoglobulin (IVIg) New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin (IVIg) Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin (IVIg) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin (IVIg) Production Comparison, (2021 & 2025 & 2032) & (K Bottle)
Table 31. United States VS China Intravenous Immunoglobulin (IVIg) Consumption Comparison, (2021 & 2025 & 2032) & (K Bottle)
Table 32. United States Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production (2021-2026) & (K Bottle)
Table 36. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 37. China Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production, (2021-2026) & (K Bottle)
Table 41. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 42. Rest of World Based Intravenous Immunoglobulin (IVIg) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production, (2021-2026) & (K Bottle)
Table 46. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share (2021-2026)
Table 47. World Intravenous Immunoglobulin (IVIg) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Intravenous Immunoglobulin (IVIg) Production by Type (2021-2026) & (K Bottle)
Table 49. World Intravenous Immunoglobulin (IVIg) Production by Type (2027-2032) & (K Bottle)
Table 50. World Intravenous Immunoglobulin (IVIg) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Intravenous Immunoglobulin (IVIg) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2026) & (USD/Bottle)
Table 53. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2027-2032) & (USD/Bottle)
Table 54. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Table 55. World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2021-2026) & (K Bottle)
Table 56. World Intravenous Immunoglobulin (IVIg) Production by Treatment Setting (2027-2032) & (K Bottle)
Table 57. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2021-2026) & (USD Million)
Table 58. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting (2027-2032) & (USD Million)
Table 59. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2026) & (USD/Bottle)
Table 60. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2027-2032) & (USD/Bottle)
Table 61. World Intravenous Immunoglobulin (IVIg) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Intravenous Immunoglobulin (IVIg) Production by Application (2021-2026) & (K Bottle)
Table 63. World Intravenous Immunoglobulin (IVIg) Production by Application (2027-2032) & (K Bottle)
Table 64. World Intravenous Immunoglobulin (IVIg) Production Value by Application (2021-2026) & (USD Million)
Table 65. World Intravenous Immunoglobulin (IVIg) Production Value by Application (2027-2032) & (USD Million)
Table 66. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2026) & (USD/Bottle)
Table 67. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2027-2032) & (USD/Bottle)
Table 68. Takeda Basic Information, Manufacturing Base and Competitors
Table 69. Takeda Major Business
Table 70. Takeda Intravenous Immunoglobulin (IVIg) Product and Services
Table 71. Takeda Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Takeda Recent Developments/Updates
Table 73. Takeda Competitive Strengths & Weaknesses
Table 74. CSL Basic Information, Manufacturing Base and Competitors
Table 75. CSL Major Business
Table 76. CSL Intravenous Immunoglobulin (IVIg) Product and Services
Table 77. CSL Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. CSL Recent Developments/Updates
Table 79. CSL Competitive Strengths & Weaknesses
Table 80. Grifols Basic Information, Manufacturing Base and Competitors
Table 81. Grifols Major Business
Table 82. Grifols Intravenous Immunoglobulin (IVIg) Product and Services
Table 83. Grifols Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Grifols Recent Developments/Updates
Table 85. Grifols Competitive Strengths & Weaknesses
Table 86. Octapharma Basic Information, Manufacturing Base and Competitors
Table 87. Octapharma Major Business
Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
Table 89. Octapharma Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Octapharma Recent Developments/Updates
Table 91. Octapharma Competitive Strengths & Weaknesses
Table 92. Kedrion Basic Information, Manufacturing Base and Competitors
Table 93. Kedrion Major Business
Table 94. Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
Table 95. Kedrion Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Kedrion Recent Developments/Updates
Table 97. Kedrion Competitive Strengths & Weaknesses
Table 98. LFB Group Basic Information, Manufacturing Base and Competitors
Table 99. LFB Group Major Business
Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
Table 101. LFB Group Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. LFB Group Recent Developments/Updates
Table 103. LFB Group Competitive Strengths & Weaknesses
Table 104. Biotest Basic Information, Manufacturing Base and Competitors
Table 105. Biotest Major Business
Table 106. Biotest Intravenous Immunoglobulin (IVIg) Product and Services
Table 107. Biotest Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Biotest Recent Developments/Updates
Table 109. Biotest Competitive Strengths & Weaknesses
Table 110. BPL Basic Information, Manufacturing Base and Competitors
Table 111. BPL Major Business
Table 112. BPL Intravenous Immunoglobulin (IVIg) Product and Services
Table 113. BPL Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. BPL Recent Developments/Updates
Table 115. BPL Competitive Strengths & Weaknesses
Table 116. RAAS Basic Information, Manufacturing Base and Competitors
Table 117. RAAS Major Business
Table 118. RAAS Intravenous Immunoglobulin (IVIg) Product and Services
Table 119. RAAS Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. RAAS Recent Developments/Updates
Table 121. RAAS Competitive Strengths & Weaknesses
Table 122. CBPO Basic Information, Manufacturing Base and Competitors
Table 123. CBPO Major Business
Table 124. CBPO Intravenous Immunoglobulin (IVIg) Product and Services
Table 125. CBPO Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. CBPO Recent Developments/Updates
Table 127. CBPO Competitive Strengths & Weaknesses
Table 128. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 129. Hualan Bio Major Business
Table 130. Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 131. Hualan Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Hualan Bio Recent Developments/Updates
Table 133. Hualan Bio Competitive Strengths & Weaknesses
Table 134. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 135. Tiantan Bio Major Business
Table 136. Tiantan Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 137. Tiantan Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Tiantan Bio Recent Developments/Updates
Table 139. Tiantan Bio Competitive Strengths & Weaknesses
Table 140. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 141. Shuanglin Bio Major Business
Table 142. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 143. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Shuanglin Bio Recent Developments/Updates
Table 145. Shuanglin Bio Competitive Strengths & Weaknesses
Table 146. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 147. Boya Bio Major Business
Table 148. Boya Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 149. Boya Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Boya Bio Recent Developments/Updates
Table 151. Boya Bio Competitive Strengths & Weaknesses
Table 152. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 153. Yuanda Shuyang Major Business
Table 154. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
Table 155. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Yuanda Shuyang Recent Developments/Updates
Table 157. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 158. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 159. Weiguang Bio Major Business
Table 160. Weiguang Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 161. Weiguang Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Weiguang Bio Recent Developments/Updates
Table 163. Weiguang Bio Competitive Strengths & Weaknesses
Table 164. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 165. Nanyue Bio Major Business
Table 166. Nanyue Bio Intravenous Immunoglobulin (IVIg) Product and Services
Table 167. Nanyue Bio Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Nanyue Bio Recent Developments/Updates
Table 169. Nanyue Bio Competitive Strengths & Weaknesses
Table 170. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 171. KM Biologics Major Business
Table 172. KM Biologics Intravenous Immunoglobulin (IVIg) Product and Services
Table 173. KM Biologics Intravenous Immunoglobulin (IVIg) Production (K Bottle), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. KM Biologics Recent Developments/Updates
Table 175. KM Biologics Competitive Strengths & Weaknesses
Table 176. Global Key Players of Intravenous Immunoglobulin (IVIg) Upstream (Raw Materials)
Table 177. Global Intravenous Immunoglobulin (IVIg) Typical Customers
Table 178. Intravenous Immunoglobulin (IVIg) Typical Distributors
LIST OF FIGURES
Figure 1. Intravenous Immunoglobulin (IVIg) Picture
Figure 2. World Intravenous Immunoglobulin (IVIg) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Intravenous Immunoglobulin (IVIg) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 5. World Intravenous Immunoglobulin (IVIg) Average Price (2021-2032) & (USD/Bottle)
Figure 6. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2021-2032)
Figure 7. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2021-2032)
Figure 8. North America Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 9. Europe Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 10. China Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 11. Intravenous Immunoglobulin (IVIg) Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 14. World Intravenous Immunoglobulin (IVIg) Consumption Market Share by Region (2021-2032)
Figure 15. United States Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 16. China Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 17. Europe Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 18. Japan Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 19. South Korea Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 20. ASEAN Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 21. India Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 22. Producer Shipments of Intravenous Immunoglobulin (IVIg) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin (IVIg) Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin (IVIg) Markets in 2025
Figure 25. United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Intravenous Immunoglobulin (IVIg) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 29. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 31. World Intravenous Immunoglobulin (IVIg) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Type in 2025
Figure 33. IVIg Liquid
Figure 34. IVIg Powder
Figure 35. World Intravenous Immunoglobulin (IVIg) Production Market Share by Type (2021-2032)
Figure 36. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Type (2021-2032)
Figure 37. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2032) & (USD/Bottle)
Figure 38. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Figure 39. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Treatment Setting in 2025
Figure 40. Low Concentration
Figure 41. Medium Concentration
Figure 42. High Concentration
Figure 43. World Intravenous Immunoglobulin (IVIg) Production Market Share by Treatment Setting (2021-2032)
Figure 44. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Treatment Setting (2021-2032)
Figure 45. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2032) & (USD/Bottle)
Figure 46. Acute Therapy
Figure 47. Maintenance Therapy
Figure 48. Critical Care
Figure 49. World Intravenous Immunoglobulin (IVIg) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Application in 2025
Figure 51. Immunodeficiency
Figure 52. Autoimmune Disease
Figure 53. Acute Infection
Figure 54. World Intravenous Immunoglobulin (IVIg) Production Market Share by Application (2021-2032)
Figure 55. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Application (2021-2032)
Figure 56. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2032) & (USD/Bottle)
Figure 57. Intravenous Immunoglobulin (IVIg) Industry Chain
Figure 58. Intravenous Immunoglobulin (IVIg) Procurement Model
Figure 59. Intravenous Immunoglobulin (IVIg) Sales Model
Figure 60. Intravenous Immunoglobulin (IVIg) Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Intravenous Immunoglobulin (IVIg) Picture
Figure 2. World Intravenous Immunoglobulin (IVIg) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Intravenous Immunoglobulin (IVIg) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 5. World Intravenous Immunoglobulin (IVIg) Average Price (2021-2032) & (USD/Bottle)
Figure 6. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Region (2021-2032)
Figure 7. World Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2021-2032)
Figure 8. North America Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 9. Europe Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 10. China Intravenous Immunoglobulin (IVIg) Production (2021-2032) & (K Bottle)
Figure 11. Intravenous Immunoglobulin (IVIg) Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 14. World Intravenous Immunoglobulin (IVIg) Consumption Market Share by Region (2021-2032)
Figure 15. United States Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 16. China Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 17. Europe Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 18. Japan Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 19. South Korea Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 20. ASEAN Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 21. India Intravenous Immunoglobulin (IVIg) Consumption (2021-2032) & (K Bottle)
Figure 22. Producer Shipments of Intravenous Immunoglobulin (IVIg) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin (IVIg) Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin (IVIg) Markets in 2025
Figure 25. United States VS China: Intravenous Immunoglobulin (IVIg) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Intravenous Immunoglobulin (IVIg) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Intravenous Immunoglobulin (IVIg) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 29. China Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Intravenous Immunoglobulin (IVIg) Production Market Share 2025
Figure 31. World Intravenous Immunoglobulin (IVIg) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Type in 2025
Figure 33. IVIg Liquid
Figure 34. IVIg Powder
Figure 35. World Intravenous Immunoglobulin (IVIg) Production Market Share by Type (2021-2032)
Figure 36. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Type (2021-2032)
Figure 37. World Intravenous Immunoglobulin (IVIg) Average Price by Type (2021-2032) & (USD/Bottle)
Figure 38. World Intravenous Immunoglobulin (IVIg) Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Figure 39. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Treatment Setting in 2025
Figure 40. Low Concentration
Figure 41. Medium Concentration
Figure 42. High Concentration
Figure 43. World Intravenous Immunoglobulin (IVIg) Production Market Share by Treatment Setting (2021-2032)
Figure 44. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Treatment Setting (2021-2032)
Figure 45. World Intravenous Immunoglobulin (IVIg) Average Price by Treatment Setting (2021-2032) & (USD/Bottle)
Figure 46. Acute Therapy
Figure 47. Maintenance Therapy
Figure 48. Critical Care
Figure 49. World Intravenous Immunoglobulin (IVIg) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Application in 2025
Figure 51. Immunodeficiency
Figure 52. Autoimmune Disease
Figure 53. Acute Infection
Figure 54. World Intravenous Immunoglobulin (IVIg) Production Market Share by Application (2021-2032)
Figure 55. World Intravenous Immunoglobulin (IVIg) Production Value Market Share by Application (2021-2032)
Figure 56. World Intravenous Immunoglobulin (IVIg) Average Price by Application (2021-2032) & (USD/Bottle)
Figure 57. Intravenous Immunoglobulin (IVIg) Industry Chain
Figure 58. Intravenous Immunoglobulin (IVIg) Procurement Model
Figure 59. Intravenous Immunoglobulin (IVIg) Sales Model
Figure 60. Intravenous Immunoglobulin (IVIg) Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
